Hypothesis

Within‑person days where sleep efficiency falls below an individual’s 20th percentile and nighttime HRV drops below the same percentile will exhibit significantly higher postprandial glucose AUC than days where only one marker is abnormal. Furthermore, performing a brief bout of light‑intensity exercise or delaying carbohydrate intake during the predicted vulnerability window will reduce glucose excursions to levels comparable to low‑risk days.

Mechanistic Rationale

Poor sleep elevates nocturnal sympathetic tone and cortisol, which impair insulin signaling and promote hepatic gluconeogenesis【1】. Low HRV reflects reduced vagal buffering and heightened catecholamine drive, further suppressing peripheral glucose uptake【2】. When both stressors co‑occur, the combined effect on hepatic glucose output and muscle insulin resistance is supra‑additive: sleep loss amplifies the glycemic impact of sympathetic surge, while low vagal tone diminishes the counter‑regulatory insulin release that normally follows a meal. This creates a transient "metabolic vulnerability window" in which the same meal produces a larger glucose excursion than predicted by either biomarker alone.

Testable Predictions

1. Prediction A – On vulnerability days (both sleep and HRV below personal thresholds), the incremental glucose AUC after a standardized breakfast will be ≥15 % higher than on non‑vulnerability days (single‑marker or normal days).
2. Prediction B – Applying a 10‑minute walk at 3 METs or shifting 20 g of breakfast carbohydrates to a later snack within the vulnerability window will reduce the glucose AUC to within 5 % of non‑vulnerability day levels.
3. Prediction C – The magnitude of glucose attenuation will correlate with the degree of HRV rebound during the intervention (r > 0.4).

Experimental Design (n=1 self‑experiment)

• Baseline period (14 days): Wear a validated sleep tracker (e.g., Oura Ring) to derive nightly sleep efficiency, a chest‑strap HRV logger (e.g., Polar H10) for nocturnal RMSSD, and a CGM (e.g., Dexcom G7) for continuous glucose. Compute personal 20th‑percentile cutoffs for each metric.
• Intervention period (28 days): Each morning, classify the prior night as vulnerable (both metrics below cutoffs) or non‑vulnerable. On vulnerable days, randomize to either (a) control (usual routine) or (b) intervention (10‑minute light walk starting 15 min before breakfast, or carbohydrate shift). On non‑vulnerable days, follow usual routine.
• Outcome: Primary – incremental glucose AUC (0‑120 min) after a fixed 50 g glucose breakfast. Secondary – peak glucose, time‑to‑peak, and subjective energy/fatigue scores.
• Analysis: Mixed‑effects model with day nested within participant, fixed effects for vulnerability status, intervention, and their interaction; random intercept for day‑to‑day variability.

Potential Confounds & Controls

• Activity: Prior‑day exercise intensity logged via accelerometer; include as covariate.
• Stress: Daily perceived stress score (0‑10) collected; adjust for acute stress.
• Meal composition: Keep breakfast macronutrient constant; log any deviations.
• Device validity: Cross‑check sleep tracker against weekly in‑home PSG subset (n=3) and HRV chest strap against weekly ECG Holter (n=3) to ensure <5 % error.

If the interaction term (vulnerability × intervention) fails to reach significance (p > 0.05) or glucose AUC on vulnerable control days does not exceed non‑vulnerable days, the hypothesis is falsified. Conversely, a significant reduction in glucose excursions only when the intervention is applied within the predicted window would support the existence of actionable, within‑person metabolic vulnerability windows.